Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Survey of UK histopathology consultants' attitudes towards academic and molecular pathology.

Brockmoeller S, Young C, Lee J, Arends MJ, Wilkins BS, Thomas GJ, Oien KA, Jones L, Hunter KD.

J Clin Pathol. 2019 Jun;72(6):399-405. doi: 10.1136/jclinpath-2018-205568. Epub 2019 Mar 25.

2.

Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features.

Godfrey AL, Campbell PJ, MacLean C, Buck G, Cook J, Temple J, Wilkins BS, Wheatley K, Nangalia J, Grinfeld J, McMullin MF, Forsyth C, Kiladjian JJ, Green AR, Harrison CN; United Kingdom Medical Research Council Primary Thrombocythemia-1 Study; United Kingdom National Cancer Research Institute Myeloproliferative Neoplasms Subgroup; French Intergroup of Myeloproliferative Neoplasms; and the Australasian Leukaemia and Lymphoma Group.

J Clin Oncol. 2018 Aug 28:JCO2018788414. doi: 10.1200/JCO.2018.78.8414. [Epub ahead of print]

3.

Management of polycythaemia vera: a critical review of current data.

McMullin MF, Wilkins BS, Harrison CN.

Br J Haematol. 2016 Feb;172(3):337-49. doi: 10.1111/bjh.13812. Epub 2015 Oct 22. Review.

PMID:
26492433
4.

How we diagnose and treat essential thrombocythaemia.

Alimam S, Wilkins BS, Harrison CN.

Br J Haematol. 2015 Nov;171(3):306-21. doi: 10.1111/bjh.13605. Epub 2015 Sep 10. Review.

PMID:
26464262
5.

Synchronous splenic and bone marrow haemangiolymphangioma: a novel entity.

Merritt AJ, Wilkins BS, Williams MS, Hay C, Byers RJ.

J Clin Pathol. 2014 Jul;67(7):645-7. doi: 10.1136/jclinpath-2014-202218. Epub 2014 Apr 24. No abstract available.

PMID:
24764325
6.

Resolution of bone marrow fibrosis in a patient receiving JAK1/JAK2 inhibitor treatment with ruxolitinib.

Wilkins BS, Radia D, Woodley C, Farhi SE, Keohane C, Harrison CN.

Haematologica. 2013 Dec;98(12):1872-6. doi: 10.3324/haematol.2013.095109. Epub 2013 Sep 20.

7.

Transformation from follicular lymphoma to biphasic high-grade large B-cell lymphoma with immunophenotypically and genetically distinct diffuse large B cell and Burkitt-like components.

Dunn RG, Foot NJ, Ffolkes L, Newell B, Wilkins BS, Neat MJ.

J Clin Pathol. 2013 Apr;66(4):357-60. doi: 10.1136/jclinpath-2012-201260. Epub 2013 Feb 15. No abstract available.

PMID:
23418341
8.

Positive JAK2-V617F leading to diagnosis of Gaucher's disease.

Appiah-Cubi S, Wilkins BS, Harrison C.

J Clin Pathol. 2012 Aug;65(8):764-5. doi: 10.1136/jclinpath-2012-200705. Epub 2012 Mar 29. No abstract available.

PMID:
22461650
9.

Fluorescence in situ hybridisation analysis of formalin-fixed paraffin-embedded tissue sections in the diagnostic work-up of non-Burkitt high grade B-cell non-Hodgkin's lymphoma: a single centre's experience.

Foot NJ, Dunn RG, Geoghegan H, Wilkins BS, Neat MJ.

J Clin Pathol. 2011 Sep;64(9):802-8. doi: 10.1136/jclinpath-2011-200015. Epub 2011 May 18.

PMID:
21593346
10.

Pitfalls in lymphoma pathology: avoiding errors in diagnosis of lymphoid tissues.

Wilkins BS.

J Clin Pathol. 2011 Jun;64(6):466-76. doi: 10.1136/jcp.2010.080846. Epub 2011 Feb 15. Review.

PMID:
21325143
11.

Pitfalls in bone marrow pathology: avoiding errors in bone marrow trephine biopsy diagnosis.

Wilkins BS.

J Clin Pathol. 2011 May;64(5):380-6. doi: 10.1136/jcp.2010.080838. Epub 2011 Feb 15. Review.

PMID:
21325142
12.

Proplatelet production and stromal fibrosis in myeloproliferative neoplasms.

Wilkins BS.

Leuk Res. 2010 Nov;34(11):1417-9. doi: 10.1016/j.leukres.2010.07.010. Epub 2010 Aug 10. Review. No abstract available.

PMID:
20701970
13.

British Society of Haematology, Slide Session presented at the Annual Scientific Meeting, Brighton 2009.

McLornan DP, Burthem J, Duncombe A, Hatton C, Hutchinson CV, Marsden K, Macartney CM, Smith-Straney T, Uprichard J, Wallis J, Webb S, Wilkins BS, McMullin MF.

Int J Lab Hematol. 2010 Dec;32(6 Pt 2):616-24. doi: 10.1111/j.1751-553X.2010.01235.x.

PMID:
20491999
14.

Making the most of bone marrow trephine biopsy.

Wilkins BS, Clark DM.

Histopathology. 2009 Dec;55(6):631-40. doi: 10.1111/j.1365-2559.2009.03353.x. Review.

PMID:
19878351
15.

Reticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapy.

Campbell PJ, Bareford D, Erber WN, Wilkins BS, Wright P, Buck G, Wheatley K, Harrison CN, Green AR.

J Clin Oncol. 2009 Jun 20;27(18):2991-9. doi: 10.1200/JCO.2008.20.3174. Epub 2009 Apr 13.

16.

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort.

Beer PA, Campbell PJ, Scott LM, Bench AJ, Erber WN, Bareford D, Wilkins BS, Reilly JT, Hasselbalch HC, Bowman R, Wheatley K, Buck G, Harrison CN, Green AR.

Blood. 2008 Jul 1;112(1):141-9. doi: 10.1182/blood-2008-01-131664. Epub 2008 May 1.

17.

FIP1L1-PDGFRA positive chronic eosinophilic leukaemia and associated central nervous system involvement.

Williams C, Kalra S, Nath U, Bown N, Wilson V, Wilkins BS, Neylon AJ.

J Clin Pathol. 2008 May;61(5):677-80. doi: 10.1136/jcp.2007.052100. Epub 2008 Feb 6.

PMID:
18256119
18.

Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes.

Wilkins BS, Erber WN, Bareford D, Buck G, Wheatley K, East CL, Paul B, Harrison CN, Green AR, Campbell PJ.

Blood. 2008 Jan 1;111(1):60-70. Epub 2007 Sep 20.

19.

Cutaneous extramedullary hemopoiesis in chronic myeloproliferative and myelodysplastic disorders.

Haniffa MA, Wilkins BS, Blasdale C, Simpson NB.

J Am Acad Dermatol. 2006 Aug;55(2 Suppl):S28-31. Review.

PMID:
16843120
20.

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

Campbell PJ, Scott LM, Buck G, Wheatley K, East CL, Marsden JT, Duffy A, Boyd EM, Bench AJ, Scott MA, Vassiliou GS, Milligan DW, Smith SR, Erber WN, Bareford D, Wilkins BS, Reilly JT, Harrison CN, Green AR; United Kingdom Myeloproliferative Disorders Study Group; Medical Research Council Adult Leukaemia Working Party; Australasian Leukaemia and Lymphoma Group.

Lancet. 2005 Dec 3;366(9501):1945-53.

PMID:
16325696
21.

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.

Harrison CN, Campbell PJ, Buck G, Wheatley K, East CL, Bareford D, Wilkins BS, van der Walt JD, Reilly JT, Grigg AP, Revell P, Woodcock BE, Green AR; United Kingdom Medical Research Council Primary Thrombocythemia 1 Study.

N Engl J Med. 2005 Jul 7;353(1):33-45.

22.

Post-transplant lymphoproliferative disorders presenting as gingival overgrowth in patients immunosuppressed with ciclosporin. A report of two cases.

Rolland SL, Seymour RA, Wilkins BS, Parry G, Thomason JM.

J Clin Periodontol. 2004 Jul;31(7):581-5.

PMID:
15191596
23.

Unusual splenic sinusoidal iron overload in sickle cell/haemoglobin D-Punjab disease.

Jiskoot PM, Halsey C, Rivers R, Bain BJ, Wilkins BS.

J Clin Pathol. 2004 May;57(5):539-40.

24.

Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma.

Obermann EC, Diss TC, Hamoudi RA, Munson P, Wilkins BS, Camozzi ML, Isaacson PG, Du MQ, Dogan A.

J Pathol. 2004 Feb;202(2):252-62.

PMID:
14743509
25.
26.
27.

Teaching cases from the Royal Marsden and St Mary's Hospitals. Case 23: an unexpected finding during investigation of thrombocytopenia.

Patel KC, Bain BJ, Wilkins BS.

Leuk Lymphoma. 2002 May;43(5):1155-7. No abstract available.

PMID:
12148902
28.

The spleen.

Wilkins BS.

Br J Haematol. 2002 May;117(2):265-74. No abstract available.

PMID:
11972508
29.

Identification of four new translocations involving FGFR1 in myeloid disorders.

Sohal J, Chase A, Mould S, Corcoran M, Oscier D, Iqbal S, Parker S, Welborn J, Harris RI, Martinelli G, Montefusco V, Sinclair P, Wilkins BS, van den Berg H, Vanstraelen D, Goldman JM, Cross NC.

Genes Chromosomes Cancer. 2001 Oct;32(2):155-63.

PMID:
11550283
30.

Lymphoma and the nervous system.

Ellison DW, Wilkins BS.

Curr Top Pathol. 2001;95:239-65. Review. No abstract available.

PMID:
11545056
31.
32.

Molecular analysis reveals somatically mutated and unmutated clonal and oligoclonal B cells in T-cell-rich B-cell lymphoma.

Hodges E, Hamid Y, Quin CT, Angus B, Wilkins BS, Wright DH, Smith JL.

J Pathol. 2000 Dec;192(4):479-87.

PMID:
11113865
33.

Selective genetic analysis of p53 immunostain positive cells.

Phelps M, Wilkins BS, Jones DB.

Mol Pathol. 2000 Jun;53(3):159-61.

34.

Amplification of PCR products in excess of 600 base pairs using DNA extracted from decalcified, paraffin wax embedded bone marrow trephine biopsies.

Wickham CL, Boyce M, Joyner MV, Sarsfield P, Wilkins BS, Jones DB, Ellard S.

Mol Pathol. 2000 Feb;53(1):19-23.

35.

Behavioural and physiological responses of sheep to 16 h transport and a novel environment post-transport.

Cockram MS, Kent JE, Goddard PJ, Waran NK, Jackson RE, Mcgilp IM, Southall EL, Amory JR, Mcconnell TI, O'Riordan T, Wilkins BS.

Vet J. 2000 Mar;159(2):139-46.

PMID:
10712801
36.
37.

Normal and neoplastic mast cells.

Wilkins BS, Bain BJ.

Br J Haematol. 1999 Jul;106(1):1. No abstract available.

PMID:
10475686
38.

Immunophenotypic characterization of stromal cells in aspirated human bone marrow samples.

Wilkins BS, Jones DB.

Exp Hematol. 1998 Oct;26(11):1061-7.

PMID:
9766446
39.
40.
41.
43.

Vascular networks within the stroma of human long-term bone marrow cultures.

Wilkins BS, Jones DB.

J Pathol. 1995 Nov;177(3):295-301.

PMID:
8551392
45.
46.
48.

Microwave antigen retrieval in immunocytochemistry: a study of 80 antibodies.

Cuevas EC, Bateman AC, Wilkins BS, Johnson PA, Williams JH, Lee AH, Jones DB, Wright DH.

J Clin Pathol. 1994 May;47(5):448-52.

49.

Extramedullary haemopoiesis in fetal and adult human spleen: a quantitative immunohistological study.

Wilkins BS, Green A, Wild AE, Jones DB.

Histopathology. 1994 Mar;24(3):241-7.

PMID:
8200625
50.

Supplemental Content

Loading ...
Support Center